NASDAQ: OMCL
Omnicell Inc Stock

$34.40-1.07 (-3.02%)
Updated Apr 10, 2026
OMCL Price
$34.40
Fair Value Price
$78.92
Market Cap
$1.56B
52 Week Low
$22.66
52 Week High
$55.00
P/E
860x
P/B
1.27x
P/S
1.76x
PEG
2.88x
Dividend Yield
N/A
Revenue
$1.18B
Earnings
$2.05M
Gross Margin
42.5%
Operating Margin
0.44%
Profit Margin
0.2%
Debt to Equity
0.6
Operating Cash Flow
$127M
Beta
0.99
Next Earnings
Apr 23, 2026
Ex-Dividend
N/A
Next Dividend
N/A

OMCL Overview

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine OMCL's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Health Information Service

Industry Rating
C
OMCL
Ranked
#15 of 46

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$17.98A
$6.13A
$2.70A
View Top Health Information Service Stocks

Be the first to know about important OMCL news, forecast changes, insider trades & much more!

OMCL News

Overview

Due Diligence Score

Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how OMCL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

OMCL ($34.40) is undervalued by 56.41% relative to our estimate of its Fair Value price of $78.92 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
OMCL ($34.40) is significantly undervalued by 56.41% relative to our estimate of its Fair Value price of $78.92 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
OMCL ($34.40) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more OMCL due diligence checks available for Premium users.

Valuation

OMCL fair value

Fair Value of OMCL stock based on Discounted Cash Flow (DCF)

Price
$34.40
Fair Value
$78.92
Undervalued by
56.41%
OMCL ($34.40) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
OMCL ($34.40) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
OMCL ($34.40) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

OMCL price to earnings (PE)

For valuing profitable companies with steady earnings

Company
860x
Industry
23.33x
Market
29.91x
OMCL is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
OMCL is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

OMCL price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
1.27x
Industry
2.72x
OMCL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

OMCL price to earnings growth (PEG)

For valuing profitable companies with growth potential

OMCL is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

OMCL's financial health

Profit margin

Revenue
$314.0M
Net Income
-$2.0M
Profit Margin
-0.6%
OMCL's Earnings (EBIT) of $5.16M... subscribe to Premium to read more.
Interest Coverage Financials
OMCL's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$2.0B
Liabilities
$742.9M
Debt to equity
0.6
OMCL's short-term assets ($680.07M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OMCL's short-term assets ($680.07M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OMCL's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
OMCL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$30.4M
Investing
-$14.4M
Financing
$9.1M
OMCL's operating cash flow ($127.30M)... subscribe to Premium to read more.
Debt Coverage Financials

OMCL vs Health Information Service Stocks

TickerZen RatingMarket Cap1d %P/EP/B
OMCLC$1.56B-3.02%860.00x1.27x
WGSC$1.75B-0.72%-81.67x5.67x
PGNYC$1.34B-1.39%23.97x2.59x
TDOCC$909.82M-2.86%-4.47x0.66x
CERTC$883.22M+2.59%-555.00x0.83x

Omnicell Stock FAQ

What is Omnicell's quote symbol?

(NASDAQ: OMCL) Omnicell trades on the NASDAQ under the ticker symbol OMCL. Omnicell stock quotes can also be displayed as NASDAQ: OMCL.

If you're new to stock investing, here's how to buy Omnicell stock.

What is the 52 week high and low for Omnicell (NASDAQ: OMCL)?

(NASDAQ: OMCL) Omnicell's 52-week high was $55.00, and its 52-week low was $22.66. It is currently -37.45% from its 52-week high and 51.81% from its 52-week low.

How much is Omnicell stock worth today?

(NASDAQ: OMCL) Omnicell currently has 45,435,918 outstanding shares. With Omnicell stock trading at $34.40 per share, the total value of Omnicell stock (market capitalization) is $1.56B.

Omnicell stock was originally listed at a price of $8.76 in Aug 9, 2001. If you had invested in Omnicell stock at $8.76, your return over the last 24 years would have been 292.69%, for an annualized return of 5.86% (not including any dividends or dividend reinvestments).

How much is Omnicell's stock price per share?

(NASDAQ: OMCL) Omnicell stock price per share is $34.40 today (as of Apr 10, 2026).

What is Omnicell's Market Cap?

(NASDAQ: OMCL) Omnicell's market cap is $1.56B, as of Apr 11, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Omnicell's market cap is calculated by multiplying OMCL's current stock price of $34.40 by OMCL's total outstanding shares of 45,435,918.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.